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Abstract
Recent associations between age-related differentially methylated sites and bivalently marked chromatin domains have
implicated a role for these genomic regions in aging and age-related diseases. However, the overlap between such
epigenetic modifications has so far only been identified with respect to age-associated hyper-methylated sites in blood. In
this study, we observed that age-associated differentially methylated sites characterized in the human brain were also
highly enriched in bivalent domains. Analysis of hyper- vs. hypo-methylated sites partitioned by age (fetal, child, and adult)
revealed that enrichment was significant for hyper-methylated sites identified in children and adults (child, fold
difference = 2.28, P= 0.0016; adult, fold difference = 4.73, P= 4.0061025); this trend was markedly more pronounced in
adults when only the top 100 most significantly hypo- and hyper-methylated sites were considered (adult, fold
difference = 10.7, P= 2.0061025). Interestingly, we found that bivalently marked genes overlapped by age-associated hyper-
methylation in the adult brain had strong involvement in biological functions related to developmental processes, including
neuronal differentiation. Our findings provide evidence that the accumulation of methylation in bivalent gene regions with
age is likely to be a common process that occurs across tissue types. Furthermore, particularly with respect to the aging
brain, this accumulation might be targeted to loci with important roles in cell differentiation and development, and the
closing off of these developmental pathways. Further study of these genes is warranted to assess their potential impact
upon the development of age-related neurological disorders.
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Introduction
Epigenetic modifications, such as DNA methylation and post-
translational modifications of histone proteins, are indispensable
for many aspects of genome function, including gene expression.
DNA methylation patterns at specific CpG-sites can vary over
time within an individual and correspondingly, age-related
methylation changes have been identified in multiple tissues and
organisms [1–8]. A recent study of changes in DNA methylation in
blood cells associated with aging revealed an enrichment of
differentially-methylated sites, specifically those exhibiting in-
creased methylation with age (hyper-methylation), in bivalently
marked regions of the genome marked by the presence of both
trimethylated lysine 4 and 27 in histone H3 (H3K4me3 and
H3K27me3 respectively)[3]. Due to the predominant effect of
H3K27me3, bivalent domains are known to take on repressed
states while remaining ‘poised’ for active gene expression, a feature
important to cell pluripotency and differentiation [9,10].
Interestingly, the accumulation of DNA methylation at bivalent
domains has been proposed to impact gene expression programs
associated with both cell differentiation and carcinogenesis [11].
Given the relationship between cancer and aging, the finding that
age-associated hyper-methylation has been shown to preferentially
occur within bivalent domains is intriguing and warrants further
study [3], and also suggests that the build up of DNA methylation
at bivalent domains with age may occur in additional tissues with
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potential roles in the pathogenesis of other age-related disorders.
In the current study, we sought to build upon our understanding of
age-associated DNA methylation by investigating whether recently
characterized age-associated DNA hyper- and hypo-methylated
loci in the human brain [8] had a similar relationship with
bivalently marked chromatin domains in human embryonic stem
cells [12].
Methods
Data acquisition and mining
Raw association data, including P-values for 27,578 genome-
wide CpG sites from [8], were kindly provided by the authors of
the study; these methylation data were generated from human
brain samples (dorsolateral prefrontal cortex) of 108 subjects using
the Illumina Infinium HumanMethylation27 BeadChip [8]. For
the current study, a Bonferonni corrected P-value (1.81304E-06)
was applied to determine CpG sites with the most significant age-
associated methylation changes within each of three age groups, as
defined by Numata et al. [8]: fetal, child (0–10 years of age), and
adult (.10 years of age). After applying this correction, sites were
first partitioned into hypo-vs. hyper-methylated sites; hyper-
methylated sites were defined as those with slopes .0.0 (i.e., those
at which methylation increased with age), whereas hypo-methyl-
ated sites were defined as those with slopes ,0.0. Data were then
further partitioned into additional subsets: (1) all significant sites
for each age group (using P-value ,1.81304E-06), (2) significant
sites unique to each age group (i.e., those sites with significant P-
values ,1.81304E-06 in a given age group that were not also
significant (P-value .1.81304E-06) in either of the other two age
groups), and (3) the top 100 most significant non-overlapping sites
per age group. In addition, CpG sites with reported age-related
changes in methylation identified in blood were also used [3,4,7],
including aging-associated differentially methylated sites from
samples of patients with type-1 diabetes [4]. When necessary,
differentially methylated sites from these studies were also
designated as either hyper- or hypo-methylated. Coordinates of
CpG probe IDs from brain and blood studies were considered as
single points in analyses below, based on the first base pair position
of each probe. For bivalent chromatin sites, gene coordinates
(+22 KB) of 1,792 previously identified genes associated with co-
methylation of H3K4 and H3K27 in human hES3 cells [12] were
used. Probe and gene coordinates were based on the hg18 (NCBI
36) human genome reference build.
Data Analysis
We used the Genomic Hyperbrowser (http://hyperbrowser.uio.
no/hb/)[13] to perform all analyses on genome coordinates.
Enrichment was defined as the ratio of the proportion of probe
coordinates covered by bivalent gene regions, to the proportion of
non-probe coordinates covered by bivalent gene regions. The
significance of overlap was tested at a whole genome scale, by
asking whether age-associated probe coordinates fell within
bivalent gene coordinates more often than expected by chance;
for this, we defined a null model in which probe coordinates were
preserved exactly, and where the positions of bivalent gene
coordinates were randomized while preserving the observed
distribution of lengths and distances between these bivalent gene
coordinates. The base pair overlap between the two tracks was
calculated for the real data, as well as for 50,000 Monte Carlo
samples from the null model. P-values were calculated as the
proportion of Monte Carlo samples being equal to or more
extreme than the observed overlap.
For comparisons of the degree of overlap observed between
bivalent gene loci and different subsets of age-associated differen-
tially methylated sites (e.g. adult brain hyper- vs. hypo-methylated
sites), case-control tracks were created for each pair of subsets. In
each instance, case and control tracks consisted of probe
coordinates unique to either of the two subsets being compared.
For this analysis, Monte Carlo simulations (n = 50,000) were
performed in which case-control labels for each of the coordinates
were permuted randomly. P-values were calculated by comparing
the observed base pair overlap between case tracks and bivalent
regions against the corresponding distribution for 50,000 Monte
Carlo samples. The fold enrichment difference in overlap between
case and control tracks was calculated as the ratio between the
proportions of case and control tracks that overlapped with
bivalent regions.
We used DAVID [14,15] to assess the biological function of
genes associated with hyper-methylated sites unique to adult brain
[8], considering those that overlapped bivalent sites compared to
those that did not [12]. Results for gene ontology were assessed
using the Functional Annotation Tool (GOTERM_BP_FAT).
Results
Enrichment of age-associated differentially methylated
sites in bivalent chromatin domains
Of the 27,578 CpG sites investigated across three age groups,
fetal, child, and adult, Numata et al. [8] identified 865, 5,506, and
10,578 loci, respectively, that exhibited age-associated changes in
DNA methylation based on a false discovery rate of 5%. To
further refine this data set, we applied a Bonferonni correction to
the uncorrected data, and compiled a list of 125 fetal, 888 child,
and 2,756 adult sites, with the most shared sites between children
and adults (child/adult, n = 439; child/fetal, n = 12; fetal/adult,
n = 14). After removing shared loci between age groups, there
were a total of 2,851 non-overlapping sites (fetal, n = 103; child,
n = 441; adult, n = 2,307; Table 1).
We tested for enrichment of brain DNA methylation sites
identified in each age group with bivalent chromatin domains. We
did this by first considering all age-associated sites in each age
group (Table 1); both adult and child sites showed significant
enrichment in bivalent gene regions (adult, enrichment = 3.06,
P=0.00002; child, enrichment = 2.81, P=0.00002), whereas the
enrichment of fetal sites in bivalent gene loci was non-significant
(enrichment = 0.79, P=0.78). Global enrichment values changed
only slightly when sites unique to each age group were tested
(adult, enrichment = 3.07, P=0.00002; child, enrichment = 2.62,
P=0.00002; fetal, enrichment = 0.80, P=0.75; Table 1).
As a point of comparison, we also tested for overlap between
bivalent gene regions and age-associated differentially methylated
sites identified in blood samples from three independent studies
[3,4,7]. Two of these used samples collected from adults [3,4], and
the third was based on sampling from two child cohorts [7]. Data
from Rakyan et al. [3] included only hyper-methylated sites
identified in blood that overlapped those identified in CD4+ T cells
and CD14+ monocytes. In all cases, sites identified from each of
these three studies showed significant overlap with bivalent gene
regions (Table 1). The highest enrichment value (12.86;
P=0.00002) was observed for sites identified in Rakyan et al.
[3], which had previously been analyzed with respect to their
overlap with bivalent sites identified in Zhao et al. [12], and was
the motivation for this study. We also tested for overlap of bivalent
gene regions and 683 differentially methylated sites identified in a
cohort of T1D patients [4] and observed a significant global
enrichment value of 5.29 (P=0.00002).
DNA Methylation at Bivalent Sites in Human Brain
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Increased enrichment of hyper- vs. hypo-methylated
sites in bivalent genes
Given the high degree of overlap between bivalent loci and sites
identified by Rakyan et al. [3](Table 1), which consisted of the top
131 most significantly differentiated hyper-methylated sites asso-
ciated with age in their samples, we attempted to further partition
age-associated sites in brain to better match this dataset. We first
partitioned data from Numata et al. [8] by hyper- versus hypo-
methylated sites unique to each age group and tested these for
enrichment in bivalent gene regions. In child and adult age
groups, hyper-methylated sites were enriched in bivalent gene
regions, whereas hypo-methylated sites were not (Table 2). In
addition, the overlap of hyper-methylated sites with bivalent gene
regions was significantly greater than hypo-methylated sites in
both children and adults (child, fold difference = 2.28, P=0.0016;
adult, fold difference = 4.73, P=0.00004; Table 2). A similar trend
was noted for fetal-only sites, although the difference between
hypo- and hyper-methylated sites was not significant (fold
difference = 4.44, P=0.099). A significant difference between the
overlap of bivalent genes observed for hyper- and hypo-
methylated sites in adult blood [4] was also observed (hyper.-
hypo, fold difference = 2.57, P=0.00002; Table 2). We next
analyzed only the top 100 methylated brain sites unique to child
and adult age groups, partitioned by hyper- and hypo-methylated
sites. Again, hyper-methylated sites showed a greater overlap with
bivalent genes, but this difference was only significant for adult
sites (child, fold difference = 2.75, P=0.052; adult, fold differ-
ence = 10.67, P=0.00002; Table 2). In addition, the top 100 adult
hyper-methylated sites in brain had a higher enrichment value
than when all unique sites were considered (enrichment = 8.09,
P=0.00002; Table 2), more similar to that observed for the
Rakyan et al. [3] dataset (enrichment = 12.86, P= P=0.00002;
Table 1). Also striking, was that when aging associated T1D sites
[4] were partitioned based on hypo- vs. hyper-methylated changes,
Table 1. Global enrichment of differentially methylated loci in bivalent chromatin domains.
Global Enrichment
bivalent sites (n=1792) P value
Brain Adult (n =2756) [8] 3.063 0.00002
Brain Child (n =888) [8] 2.814 0.00002
Brain Fetal (n =125) [8] 0.7914 0.7809
Brain Adult only (n =2307) [8] 3.066 0.00002
Brain Child only (n =441) [8] 2.616 0.00002
Brain Fetal only (n =103) [8] 0.8008 0.7491
Rakyan et al. [3] (n = 131) 12.86 0.00002
Alisch et al. [7] (n =2026) 2.09 0.00002
Teschendorff et al. ‘S3’ [4] (n = 583) 3.495 0.00002
Teschendorff et al. ‘S5’ [4], T1D (n=683) 5.294 0.00002
doi:10.1371/journal.pone.0043840.t001
Table 2. Comparing global enrichment of hypo- vs. hyper-methylated loci in bivalent chromatin domains.
Global Enrichment Is overlap for hyper sites . hypo sites?
bivalent sites
(n =1792) P value Fold difference P value
Brain Adult only, hypo (n=440) [8] 0.9055 0.752
Brain Adult only, hyper (n =1867) [8] 3.659 0.00002 4.727 0.00004
Brain Child only, hypo (n=154) [8] 1.326 0.2618
Brain Child only, hyper (n =287) [8] 3.392 0.00002 2.28 0.00164
Brain Fetal only, hypo (n=83) [8] 0.3875 0.9572
Brain Fetal only, hyper (n =20) [8] 2.77 0.1299 4.446 0.09896
Brain Adult only, hypo (top 100) [8] 0.654 0.8946
Brain Adult only, hyper (top 100) [8] 8.085 0.00002 10.67 0.00002
Brain Child only, hypo (top 100) [8] 1.365 0.2754
Brain Child only, hyper (top 100) [8] 4.427 0.00006 2.75 0.05192
Blood Adult hypo (n =360) [4] 2.017 0.00094
Blood Adult hyper (n=223) [4] 6.498 0.00002 2.571 0.00002
Adult T1D, hypo (n=278) [4] 1.365 0.1393
Adult T1D, hyper (n =405) [4] 9.255 0.00002 4.637 0.00002
doi:10.1371/journal.pone.0043840.t002
DNA Methylation at Bivalent Sites in Human Brain
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hyper-methylated sites also exhibited a much higher enrichment
compared to hypo-methylated sites (fold difference = 4.64,
P=0.00002; Table 2).
Functional characterization of hyper-methylated adult
brain/bivalent genes
We next sought to determine whether there were differences in
biological function of adult brain hyper-methylated genes that
overlapped bivalent loci compared to those that did not overlap
bivalent loci. Of the 1,867 brain hyper-methylated sites unique to
adults, 353 overlapped bivalent loci, corresponding to 304 non-
redundant genes. The 1,514 hyper-methylated sites that did not
overlap bivalent loci corresponded to 1,410 non-redundant genes.
A qualitative comparison of the top ten most significant biological
functions of these two groups of genes is shown in Table 3. Not
surprisingly, given that bivalent domains are known to associate
with genes involved in development, eight of the ten biological
functions identified for adult brain hyper-methylated/bivalent sites
shared the parent GO term ‘‘developmental process’’
(GO:0032502). Notably, among these was the term ‘‘neuron
differentiation’’ (4.90610213; GO:0030182), which is defined as
‘‘the process in which a relatively unspecialized cell acquires
specialized features of a neuron’’. In contrast, none of the
biological functions identified for those sites outside of bivalent
domains were associated with GO:0032502; in addition, only four
of these had P-values ,0.05.
Discussion
Age-associated DNA hyper-methylated sites in blood have been
shown to overlap bivalent chromatin domains [3], which involve
genes with functions in development and cellular differentiation
[10]. Here we have confirmed the occurrence of such an overlap
in additional datasets from blood, and revealed that genomic
regions associated with age-related changes in DNA methylation
in the human brain are also enriched in bivalent domains,
suggesting that this phenomenon is likely ubiquitous, occurring
across different tissue types.
Regarding the relationship between brain age-associated DNA
methylated sites and bivalent domains, we noted two primary
trends: (1) that overlap of these sites was largely driven by DNA
hyper-methylation, as hyper-methylated sites were more enriched
in bivalent domains than hypo-methylated sites; and (2) that this
enrichment was more pronounced for sites associated with DNA
hyper-methylation that occurred in adulthood. Numata et al. [8]
noted that DNA hyper-methylated sites represented a larger
proportion of age-associated changes in adults compared to
children, and discussed the fact that such trends may be consistent
with the observation that stochastic changes in DNA methylation
are known to increase with age [16]. Importantly, stochastic
changes in DNA methylation have also been implicated in disease
discordance between monozygotic twins [17,18], including
Alzheimer’s disease [18].
But why DNA hyper-methylated sites show preferential overlap
with bivalently marked genes, and whether these sites have roles in
disease pathogenesis remains to be determined. Rakyan et al. [3]
Table 3. Gene ontology results for brain hyper-methylated sites inside and outside bivalent chromatin domains.
Top ten biological functions for brain hyper-methylated adult-only sites overlapping bivalent genes
GO Term (biological function) # of genes Benjamini P value
pattern specification process 41 1.30610221
embryonic morphogenesis 41 1.40610219
regionalization 31 2.90610216
regulation of transcription, DNA-dependent 89 2.90610216
regulation of RNA metabolic process 90 2.80610216
skeletal system development 37 8.50610216
embryonic organ development 28 3.50610215
embryonic organ morphogenesis 25 7.70610215
neuron differentiation 39 4.90610213
anterior/posterior pattern formation 23 3.00610212
Top ten biological functions for brain hyper-methylated adult-only sites not overlapping bivalent genes
GO Term (biological function) # of genes Benjamini P value
immune response 84 3.00610202
cell proliferation 59 2.00610202
negative regulation of cell proliferation 51 1.80610202
defense response 74 4.10610202
regulation of cell proliferation 89 5.10610202
intracellular signaling cascade 128 1.10610201
regulation of protein transport 21 1.30610201
response to drug 32 1.40610201
regulation of apoptosis 87 1.40610201
regulation of programmed cell death 87 1.80610201
doi:10.1371/journal.pone.0043840.t003
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posited that increased DNA hyper-methylation at bivalent
domains with age may be associated with a decrease in cellular
and developmental pluripotency, in line with observations from in
vitro studies using human cell lines [19]. Interestingly, with respect
to the brain data analyzed here, we found that a subset of genes
characterized by both age-associated DNA hyper-methylation and
bivalent chromatin marks were enriched for the biological function
‘‘neuron differentiation’’. Under a model such as that proposed by
Rakyan et al. [3], and considering the two primary trends noted
above, it could be speculated that the accumulation of methylation
(typically associated with decreased gene expression) at bivalent
loci in the aging brain could prevent neuronal cell regeneration.
Thus, given that one of the primary pathologic features of age-
related neurological disorders such as Alzheimer’s disease and
Parkinson’s disease includes the loss of neuronal cell plasticity and
cell death [20,21], the relationship between the epigenetic
alterations investigated in this study could have involvement in
the onset or the progression of such disorders, and warrants
further study.
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